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ABSTRACT 
 
Jehovah’s Witness followers pose a clinical dilemma to the medical practitioners due to their religious belief 
of an absolute prohibition of blood transfusion under any circumstances. We present a case of Jehovah’s 
Witness follower who underwent an ultra-low anterior resection for rectal cancer after neo-adjuvant          
chemo-radiotherapy. The challenges in the perioperative management are highlighted and managed          
accordingly. 
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INTRODUCTION 
 
Jehovah’s Witness is a movement within the 
Christian faith that has a distinct interpretation of 
the Christian faith as compared to the mainstream 
Christianity. Members of this faith interpret 
passages from the Old and New Testament that 
they should abstain from blood. They consider 
blood to be sacred as it is a gift of life from God. 
Thus, management of Jehovah’s Witness followers 
have been frequently quoted in literature as 
technically challenging to the medical practitioners 
due to their religious belief of absolute refusal         
of blood transfusion including autologous 
transfusion.1,2,3 
 
In Malaysia, the number of Jehovah’s Witness is 
small compared to the western countries. Thus, 
managing a Jehovah’s Witness follower patient 
requiring a major surgical procedure provides an 
opportunity to apply the principles of bloodless 
surgery when allogeneic transfusion is not 
permitted. Multidisciplinary approach with specific 
clinical strategies are needed to enhance 
erythropoiesis, effectively maximising oxygen 
delivery, minimising oxygen consumption both 
intraoperative/postoperatively and incorporating 
bloodless surgical techniques.1 We present a case of 
Jehovah’s Witness follower who underwent an 
ultralow anterior resection for a low rectal cancer 




A 60-year-old lady Jehovah’s Witness presented with 
a 3-month history of per rectal bleeding and 
constipation. She had been investigated for mild 
anaemia and diagnosed to have a thalassaemia trait 
5 years earlier. Digital rectal examination revealed a 
circumferential exophytic tumor 5 cm from the          
anal verge. Colonoscopy and biopsy confirmed 
adenocarcinoma. Computed tomography (CT) scan of 
the thorax and abdomen revealed a single liver 
nodule suspicious of metastasis. Magnetic resonance 
imaging (MRI) of the pelvis revealed a T4N0 disease of 
low rectal cancer. The carcinoembryonic antigen 
(CEA) level was 1.4 ng/ml. Clinical staging was 
T4N0M1 
 
She received neo-adjuvant concurrent chemo-
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fractions over 5 weeks and two 14-day cycles of 
Capacetabine (Xeloda) 1gm twice daily. She then 
underwent ultra-low anterior resection 12 weeks 
after the CCRT. 
 
Prior to the operation, her hemoglobin was 10g/dl. 
She expressed total refusal of transfusion of blood 
or blood products, no storage of her blood away 
from her body even in a critically ill situation and 
her willingness to perish without blood transfusion 
even if it was urgently required. Eventually, she 
agreed for specific components of blood to be used: 
cryoprecipitate, albumin and specific coagulation 
factors. She was given a dose of intravenous venofer 
(iron sucrose) 2 doses and subcutaneous 
recombinant erythropoietin 4000 unit of 3 doses for 
1 week preoperatively and continued post surgery. 
Her final haemoglobin level after optimisation was 
12 g/dl. 
 
Intraoperatively, the anaesthetist employed the 
permissive hypotension approach with Mean Arterial 
Pressure (MAP) maintained at 50-65 mmHg to 
reduce risk of bleeding. She also received a single 
dose of tranexamic acid at induction. We performed 
an ultra low anterior resection with a de-functioning 
stoma. Intraoperative bleeding was minimal with 
estimated blood loss not more than 100mL. 
 
Post operatively, she received further doses of 
intravenous iron and erythropoietin to increase red 
cell mass and bloodless surgery was successful with 




Preparing a Jehovah’s Witness for surgery is of 
interest and the principles can be applied in other 
patients as well. In recent years, attention has 
focused on the association between post operative 
blood transfusion and complications such as 
anastomotic leak, infection and long term disease 
progression.10 The concept of immunomodulation 
and triggering the release of growth factors from 
red blood cells has been implicated for cancer 
recurrence and impact on the overall disease free 
survival. According to Abu-Ghanem et.al 26.8% of 
500 laparoscopic colorectal surgery received blood 
transfusion, and the risk of transfusion is highest in 
patients with low preoperative hemoglobin, low 
rectal surgery, malignancy and presence of medical 
comorbidities.10 These factors can be utilized to 
screen patients who would most probably need 
transfusion for alternative methods to avoid 
allogeneic transfusion. 
 
A study in a bloodless centre in Soonchunhyang 
University Hospital in Korea has recruited over 1400 
patients over 10 years of whom 94% were Jehovah’s 
Witnesses. Although overall mortality was less than 
1%, however the patients with hemoglobin less than 
7 g/dl and with difference of hemoglobin post/
preoperative >50%, has an increased risk of 
cardiovascular complication and cerebrovascular 
accident.4 Thus bloodless surgery is not without 
complication and low hemoglobin level is associated 
with prolong hospital stay in postoperative 
individuals.6 The most crucial part of preparing this 
patient for surgery is counseling and fulfillment of 
advance health directive. Areas that need to be 
considered in discussion with patient includes 
acceptability of plasma derivatives, use of blood 
salvage techniques, the alternatives to blood 
transfusion and the risk of death in case of 
uncontrolled bleeding.5 Formalized legally advance 
directive should be taken as precaution and options 
of minor fractions such as coagulation factors, 
albumin, thrombin concentrate should be discussed 
as this fall under individual consideration.6,7 Thus 
discussion regarding acceptance of life saving 
transfusion in the event of similar condition should 
be well written to prevent medico legal 
consequences.  
 
Among preoperative strategy includes thorough 
history of bleeding tendencies, or chronic diseases, 
enhance erythropoiesis by increasing red cell mass, 
and in particular, for a patient with malignancy, 
correction of anaemia or coagulopathy should begin 
first prior to commencement of chemotherapy and 
surgery.1,5 Patient in this case report is at risk of 
being anaemic pre-operatively due to her 
thalassaemia trait diagnosed 5 years earlier, post 
neoadjuvant chemotherapy and from chronic 
diseases. Correction of anaemia should include 
treating folate, vitamin B or iron deficiencies and 
giving recombinant erythropoietin ideally four          
to eight weeks before surgery.6  
 
However, erythropoietin is not without risks with 
known complications include hypertension and 
thrombosis.  Other aspects include modifying drugs 
that can affect bleeding such as antiplatelet. 
Consultation with hematologist should be sought and 
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stimulating factor (G-CSF) have an important role in 




Managing a Jehovah’s Witness who needs to undergo 
surgery involves multidisciplinary team effort and 
thorough preoperative counseling. Although the ‘no 
transfusion directive’ gives a restriction to involved 
medical practitioners, the principle of bloodless 
surgery can be applied to other patients undergoing 
colorectal surgery as well, with regards to 
transfusion avoidance strategies. 
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Other options to discuss especially in oncological 
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such as radiofrequency ablation (RFA) for certain 
malignancies.5 However in this patient, 2 out of 3 of 
the above are not among the appropriate options, 
while blood salvage technique is not the best option 
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anaesthetic and surgeon’s role. Among anaesthetist 
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an alternative to prevent bleeding complications.7 
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diathermy dissection, harmonic scalpel and local 
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Post operative managements include adequate 
sedation, ventilation and pain control to minimize 
oxygen demand and maximize oxygen delivery. 
Early breathing exercise and lung expansion 
manoeuvre is instituted, while any bleeding 
detected early should be acted upon. Continuation 
of recombinant erythropoietin, iron and adequate 
gastrointestinal bleeding prophylaxis should be 
continued. 
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